Consensus ESG Ratings
Member Sign In
ESG News For Organogenesis Holdings Inc
These sites contributed news to this page:
-
The Pershing Square Foundation’s 2026 MIND (Maximizing Innovation in Neuroscience Discovery) Prize Opens for Applications
The Pershing Square Foundation today announced the opening of applications for the 2026 MIND (Maximizing Innovation in Neuroscience Discovery) Prize. Since the Prize launched in 2023, it has been awarded to 20 multidisciplinary investigators from institutions across the country. The annual prize awards $250,000 per year for three years ($750,000 total) to at least six scientists looking to uncover a deeper understanding of the brain and cognition, with a lens on Alzheimer’s Disease and Dementias -
The Pershing Square Foundation “MIND” Prize Awarded to Seven Creative Researchers Paving the Way to a Deeper and Transformative Understanding of the Brain
Each Prize Winner to Receive $750,000 Over Three Years -
First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation
Armenia and Nepal are the first of 29 countries to receive BRUKINSA